These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 34418162)
1. Association between serum fibroblast growth factor-23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease. Miyakawa H; Hsu HH; Ogawa M; Akabane R; Miyagawa Y; Takemura N J Vet Intern Med; 2021 Sep; 35(5):2296-2305. PubMed ID: 34418162 [TBL] [Abstract][Full Text] [Related]
2. Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease. Harjes LM; Parker VJ; Dembek K; Young GS; Giovaninni LH; Kogika MM; Chew DJ; Toribio RE J Vet Intern Med; 2017 May; 31(3):784-790. PubMed ID: 28419560 [TBL] [Abstract][Full Text] [Related]
3. Factors associated with survival in dogs with chronic kidney disease. Rudinsky AJ; Harjes LM; Byron J; Chew DJ; Toribio RE; Langston C; Parker VJ J Vet Intern Med; 2018 Nov; 32(6):1977-1982. PubMed ID: 30325060 [TBL] [Abstract][Full Text] [Related]
4. Serum fibroblast growth factor 23 (FGF-23): associations with hyperphosphatemia and clinical staging of feline chronic kidney disease. Lin J; Lin L; Chen S; Yu L; Chen S; Xia Z J Vet Diagn Invest; 2021 Mar; 33(2):288-293. PubMed ID: 33543676 [TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor-23 as an early marker of CKD-mineral bone disorder in dogs: preliminary investigation. Miyakawa H; Nagatani Y; Ogawa M; Nagakawa M; Sakatani A; Akabane R; Miyagawa Y; Takemura N J Small Anim Pract; 2020 Dec; 61(12):744-751. PubMed ID: 33037651 [TBL] [Abstract][Full Text] [Related]
6. Effects of calcifediol supplementation on markers of chronic kidney disease-mineral and bone disorder in dogs with chronic kidney disease. Parker VJ; Rudinsky AJ; Benedict JA; Beizaei A; Chew DJ J Vet Intern Med; 2020 Nov; 34(6):2497-2506. PubMed ID: 33128421 [TBL] [Abstract][Full Text] [Related]
7. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease. Parker VJ; Harjes LM; Dembek K; Young GS; Chew DJ; Toribio RE J Vet Intern Med; 2017 May; 31(3):791-798. PubMed ID: 28186657 [TBL] [Abstract][Full Text] [Related]
8. Effect of Dietary Phosphorous Restriction on Fibroblast Growth 2 Factor-23 and sKlotho Levels in Patients with Stages 1-2 Chronic Kidney Disease. Saxena A; Sachan T; Gupta A; Kapoor V Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014808 [TBL] [Abstract][Full Text] [Related]
9. Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy. Liao HW; Hung PH; Hsiao CY; Liou HH; Lin HS; Huang TH; Jou IM; Tsai KJ PLoS One; 2015; 10(7):e0133278. PubMed ID: 26186634 [TBL] [Abstract][Full Text] [Related]
10. Investigation on urinary and serum alpha klotho in dogs with chronic kidney disease. Yi HJ; Lee JB; Lee KP; Oh YI; Song KH; Seo KW BMC Vet Res; 2020 Jul; 16(1):246. PubMed ID: 32677951 [TBL] [Abstract][Full Text] [Related]
11. Serum fibroblast growth factor-23 concentrations in young and mature adult cats with chronic kidney disease. Miyakawa H; Hsu HH; Ogawa M; Akabane R; Miyagawa Y; Takemura N J Feline Med Surg; 2022 Aug; 24(8):815-820. PubMed ID: 34431737 [TBL] [Abstract][Full Text] [Related]
13. Serum fibroblast growth factor 23 concentrations in dogs with chronic kidney disease. Dittmer KE; Perera KC; Elder PA Res Vet Sci; 2017 Oct; 114():348-350. PubMed ID: 28667925 [TBL] [Abstract][Full Text] [Related]
14. Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Survival Time in Cats with Chronic Kidney Disease. Geddes RF; Elliott J; Syme HM J Vet Intern Med; 2015; 29(6):1494-501. PubMed ID: 26403212 [TBL] [Abstract][Full Text] [Related]
15. [The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease]. Mukhin NA; Milovanov YS; Kozlovskaya LV; Dobrosmyslov IA; Milovanova LY Ter Arkh; 2016; 88(4):41-45. PubMed ID: 27070162 [TBL] [Abstract][Full Text] [Related]
16. FGF-23 and Phosphate in Children with Chronic Kidney Disease: A Cross-Sectional Study in Kazakhstan. Balmukhanova A; Kabulbayev K; Alpay H; Kanatbayeva A; Balmukhanova A Medicina (Kaunas); 2020 Dec; 57(1):. PubMed ID: 33379157 [No Abstract] [Full Text] [Related]
17. The association of indoxyl sulfate with fibroblast growth factor-23 in cats with chronic kidney disease. Liao YL; Chou CC; Lee YJ J Vet Intern Med; 2019 Mar; 33(2):686-693. PubMed ID: 30779214 [TBL] [Abstract][Full Text] [Related]
18. The effect of feeding a renal diet on plasma fibroblast growth factor 23 concentrations in cats with stable azotemic chronic kidney disease. Geddes RF; Elliott J; Syme HM J Vet Intern Med; 2013; 27(6):1354-61. PubMed ID: 24010686 [TBL] [Abstract][Full Text] [Related]
19. Nephron index rather than serum FGF 23 predicts endothelial dysfunction in early but not advanced chronic kidney disease patients. Khreba N; Khedr D; Abdel-Baky A; Kannishy GE; Samaan E Int Urol Nephrol; 2023 Dec; 55(12):3159-3165. PubMed ID: 37043155 [TBL] [Abstract][Full Text] [Related]
20. Urinary Fractional Excretion of Phosphorus in Dogs with Spontaneous Chronic Kidney Disease. Martorelli CR; Kogika MM; Chacar FC; Caragelasco DS; de Campos Fonseca Pinto ACB; Lorigados CAB; Andrade LC Vet Sci; 2017 Dec; 4(4):. PubMed ID: 29240673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]